Research Updates

Back to project

Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu syndrome): update of October 5, 2026

What's new and why it matters

  1. A patient with Hereditary Hemorrhagic Telangiectasia had a novel gene mutation and suffered a stroke, highlighting a potential complication of the condition. Based on: 1
  2. A review found that microsurgery was the most effective treatment for unruptured brain arteriovenous malformations. Based on: 2
  3. Most brain vascular malformations in patients with HHT did not grow over time, suggesting they may not be harmful. Based on: 3
  4. Research showed that losing the SMAD4 gene can lead to issues with blood vessel structure in HHT patients. Based on: 4
  5. A new study aims to understand pregnancy complications in women with rare vascular diseases to improve health outcomes for mothers and their babies. Based on: 9

Materials in this update

  1. A Novel GDF2 Mutation in a Patient With Hereditary Hemorrhagic Telangiectasia Complicated by Acute Cerebral Infarction.
    PubMed

    Oct 3, 2026

    A patient with Hereditary Hemorrhagic Telangiectasia had a novel gene mutation related to her condition and experienced a stroke.

  2. Comparative treatment outcomes of management modalities for unruptured brain arteriovenous malformations: a systematic review and meta-analysis of 6,124 patients.
    PubMed

    Oct 2, 2026

    A review compared different treatments for unruptured brain arteriovenous malformations, finding microsurgery was the most effective.

  3. Natural history of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a longitudinal neuroimaging study and review of the literature.
    PubMed

    Oct 2, 2026

    A small study showed that most brain vascular malformations in HHT patients did not grow over time, indicating a potentially benign nature.

  4. Loss of Smad4 drives vascular malformations via c-KIT-dependent high-fluid shear stress mimicry.
    PubMed

    Oct 1, 2026

    Research found that losing a specific gene, SMAD4, affects blood vessel structure and could lead to vascular malformations in HHT.

  5. c-KIT expands the tool kit for treating arteriovenous malformation.
    PubMed

    Oct 1, 2026

    Studies highlighted the role of a protein called c-KIT in HHT and suggested it could be a potential target for treatment.

  6. Resistant Hypertension Secondary to Renal Arteriovenous Malformation: A Case of Cure After Nephrectomy.
    PubMed

    Oct 1, 2026

    A case reported significant improvement in blood pressure after surgery for a rare kidney malformation causing resistant hypertension.

  7. "Multimodal Combined Treatment of a Ruptured Cerebellar Arteriovenous Malformation: A Report".
    PubMed

    Sep 30, 2026

    A combined treatment approach for a ruptured brain arteriovenous malformation led to better recovery outcomes compared to single treatments.

  8. Successful coil-only transcatheter embolisation of a giant cervical arteriovenous malformation in a child: a case report.
    PubMed

    Sep 29, 2026

    A child’s giant cervical arteriovenous malformation was successfully treated using only coil embolization, showing promise for this method.

  9. Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study
    Clinical trials

    Registered study, no results yet

    Sep 28, 2026

    A study aims to explore pregnancy complications in women with rare vascular disorders to enhance maternal and fetal health outcomes.

  10. Severe Recurrent Gastrointestinal Bleeding Leading to the Diagnosis of Hereditary Hemorrhagic Telangiectasia: Clinical Response to Systemic Bevacizumab in a Case Report and Narrative Review.
    PubMed

    Sep 27, 2026

    A patient with severe gastrointestinal bleeding related to HHT showed less bleeding after treatment with systemic therapy involving bevacizumab.

All updates for Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu syndrome)
Email language